Identification of a novel complex between human kallikrein 2 and protease inhibitor-6 in prostate cancer tissue

Cancer Research

Volumn 59, Issue 16, 1999, Pages 3927-3930

  Mikolajczyk, Stephen D ^a   Millar, Lisa S ^a   Marker, Kathy M ^a   Rittenhouse, Harry G ^a   Wolfert, Robert L ^a   Marks, Leonard S ^b   Charlesworth, M Cristine ^c   Tindall, Donald J ^c  

^a Hybritech Incorporated   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KALLIKREIN; PROSTATE SPECIFIC ANTIGEN; PROTEINASE INHIBITOR;

AMINO TERMINAL SEQUENCE; ANTIBODY SPECIFICITY; ARTICLE; COMPLEX FORMATION; ENZYME INHIBITOR COMPLEX; EPITHELIUM CELL; HUMAN; HUMAN TISSUE; MULTIGENE FAMILY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEINASE INHIBITION; SEMINAL PLASMA;

CYTOPLASM; HUMANS; KALLIKREINS; MALE; PROSTATIC NEOPLASMS; PROTEIN BINDING; SERINE PROTEINASE INHIBITORS; SERPINS; TISSUE KALLIKREINS; TUMOR MARKERS, BIOLOGICAL;

EID: 0033567105     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Rittenhouse, H. G., Finlay, J. A., Mikolajczyk, S. D., and Partin, A. W. Human kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate. Crit. Rev. Clin. Lab. Sci., 35: 275-368, 1998.
2. Finlay, J. A., Evans, C. L., Day, J. R., Payne, J. K., Mikolajczyk, S. D., Millar, L. S., Kuus-Reichel, K., Wolfert, R. L., and Rittenhouse, H. G. Development of monoclonal antibodies specific for human glandular kallikrein (hK2): development of a dual antibody immunoassay for hK2 with negligible prostate-specific antigen cross-reactivity. Urology, 51: 804-809, 1998.
3. Darson, M. F., Parcelli, A., Roche, P., Rittenhouse, H. G., Wolfert, R. L., Young, C. Y. F., Klee, G. G., Tindall, D. J., and Bostwick, D. G. Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker. Urology, 49: 857-862, 1997.
4. Frenette, G., Tremblay, R. R., Lazure, C., and Dube, J. Y. Prostatic kallikrein (hk2), but not prostate-specific antigen (hk3), activates single-chain urokinase-type plasminogen activator. Int. J. Cancer, 71: 897-899, 1997.
5. Takayama, T. K., Fujikawa, K., and Davie, E. W. Characterization of the precursor of prostate-specific antigen activation by trypsin and by human glandular kallikrein. J. Biol. Chem., 272: 21582-21588, 1997.
6. Mikolajczyk, S. D., Millar, L. S., Kumar, A., and Saedi, M. S. Human kallikrein 2 (hK2) inactivates and complexes with plasminogen activator inhibitor-1 (PAI-1). Int. J. Cancer, 81: 438-442, 1999.
7. Morgenstern, K. A., Henzel, W. J., Baker, J. B., Wong, S., Pastuszyn, A., and Kisiel, W. Isolation and characterization of an intracellular serine proteinase inhibitor from a monkey kidney epithelial cell line. J. Biol. Chem., 268: 21560-21568, 1993.
8. Coughlin, P. B., Tetaz, T., and Salem, H. H. Identification and purification of a novel serine proteinase inhibitor. J. Biol. Chem., 268: 9541-9547, 1993.
9. Coughlin, P., Sun, J., Cerruti, L., Salem, H. H., and Bird, P. Cloning and molecular characterization of a human intracellular serine proteinase inhibitor. Proc. Natl. Acad. Sci. USA, 90: 9417-9421, 1993.
10. Scott, F. L., Coughlin, P. B., Bird, C., Cerruti, L., Hayman, J. A., and Bird, P. Proteinase inhibitor 6 cannot be secreted, which suggests it is a new type of cellular serpin. J. Biol. Chem., 271: 1605-1612, 1996.
11. 217 is important for the catalytic function and autoactivation of prostate-specific human kallikrein 2. Eur. J. Biochem., 246: 440-446, 1997.
12. Kumar, A., Goel, A., Hill, T., Mikolajczyk, S., Millar, L., Kuus-Reichel, K., and Saedi, M. Expression of human glandular kallikrein, hK2, in mammalian cells. Cancer Res., 56: 5397-5402, 1996.
13. Grauer, L. S., Finlay, J. A., Mikolajczyk, S. D., Pusateri, K. D., and Wolfert, R. L. Detection of human glandular kallikrein, hK2 as its precursor form, and in complex with protease inhibitors in prostate carcinoma serum. J. Androl., 19: 407-411, 1998.
14. Frenette, G., Deperthes, D., Tremblay, R. R., Lazure, C., and Dube, J. Y. Purification of enzymatically active kallikrein hK2 from human seminal plasma. Biochim. Biophys. Acta, 1334: 109-115, 1997.
15. Deperthes, D., Chapdelaine, P., Tremblay, R. R., Brunet, C., Berton, J., Hebert, J., Lazure, C., and Dube, J. Y. Isolation of prostatic kallikrein hK2, also known as hGK-1, in human seminal plasma. Biochim. Biophys. Acta, 1245: 311-316, 1995.
16. Riewald, M., and Schleef, R. R. Human cytoplasmic antiproteinase neutralizes rapidly and efficiently chymotrypsin and trypsin-like proteases utilizing distinct reactive site residues. J. Biol. Chem., 271: 14526-14532, 1996.